Aesculetin-induced apoptosis through a ROS-mediated mitochondrial dysfunction pathway in human cervical cancer cells

Journal of Asian Natural Products Research

Volumn 12, Issue 3, 2010, Pages 185-193

  Yang, Jin ^a   Xiao, Yu Ling ^a   He, Xian Ran ^a   Qiu, Guo Fu ^a   Hu, Xian Ming ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Aesculetin; Apoptosis; HeLa cells; Mitochondrial

Indexed keywords

CASPASE; CYTOCHROME C; ESCULETIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; IC 50; MITOCHONDRION; PROTEIN DEGRADATION; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BISBENZIMIDAZOLE; CASPASES; CYTOCHROMES C; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HELA CELLS; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PLANTS, MEDICINAL; TUMOR CELLS, CULTURED; UMBELLIFERONES; UTERINE CERVICAL NEOPLASMS;

EID: 77951474131     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020903427336     Document Type: Article

References (25)

1. A. Tubaro, N.P. Del, E. Ragazzi, S. Zampiron, and L.R. Della, Pharmacol. Res. Commun. 20, 83 (1988).
2. H.C. Huang, M.W. Lai, H.R. Wang, Y.L. Chung, L.M. Hsieh, and C.C. Chen, Eur. J. Pharmacol. 237, 39 (1993).
3. K. Matsunaga, N. Yoshimi, Y. Yamada, M. Shimizu, K. Kawabata, Y. Ozawa, A. Hara, and H. Mori, Jpn J. Cancer Res. 89, 496 (1998).
4. S.S. Hecht, P.M. Kenney, M. Wang, N. Trushin, S. Agarwal, A.V. Rao, and P. Upadhyaya, Cancer Lett. 137, 123 (1999).
5. P.T. Thuong, T.M. Hung, T.M. Nqoc, D.T. Ha, B.S. Min, S.J. Kwack, T.S. Kang, J.S. Choi, and K. Bae, Phytother. Res. (2009), doi: 10.1002/ptr.2890.
6. W.J. Ding, Y. Deng, H. Feng, W.W. Liu, R. Hu, X. Li, Z.M. Gu, and X.P. Dong, World J. Gastroenterol. 15, 1518 (2009).
7. C.K. Hsing, J.L. Herng, C.H. Chao, I.S. Han, and H.T. Tsui, Toxicol. Appl. Pharmacol. 210, 55 (2006).
8. C. Park, C.Y. Jin, G.Y. Kim, I.W. Choi, T.K. Kwon, B.T. Choi, S.J. Lee, W.H. Lee, and Y.H. Choi, Toxicol. Appl. Pharmacol. 227, 219 (2008).
9. D.M. Parkin, Lancet Oncol. 2, 533 (2001).
10. L.A. Smets, Anticancer Drugs 5, 3 (1994).
11. Y. Wang, E.M. Perchellet, M.M. Ward, K. Lou, H. Zhao, S.K. Battina, B. Wiredu, D.H. Hua, and J.P. Perchellet, Int. J. Oncol. 28, 161 (2006).
12. W.S. Chang, C.C. Lin, S.C. Chuang, and H.C. Chiang, Am. J. Chin. Med. 24, 11 (1996).
13. J. Yue and J. Xu, J. Nat. Prod. 60, 1031 (1997).
14. A.S. Martin, J.M. Benedi, and A.M. Villar, Gerontology 44, 21 (1998).
15. W.L. Lin, C.J. Wang, Y.Y. Tsai, C.L. Liu, J.M. Hwang, and T.H. Tseng, Arch. Toxicol. 74, 467 (2000).
16. T. Neichi, Y. Koshihara, and S. Murota, Biochim. Biophys. Acta 753, 130 (1983).
17. J.Y. Yang, M.A. Della-Fera, and C.A. Baile, Apoptosis 11, 1371 (2006).
18. S.L. Pan, Y.W. Huang, J.H. Guh, Y.L. Chang, C.Y. Peng, and C.M. Teng, Biochem. Pharmacol. 65, 1897 (2003).
19. J.M. Pezzuto, Biochem. Pharmacol. 53, 121 (1997).
20. J.M. Adams, Genes Dev. 17, 2481 (2003).
21. D.H. Hua and J.P. Perchellet, Int. J. Oncol. 28, 161 (2006).
22. T. Mosmann, J. Immunol. Methods 65, 55 (1983).
23. A. Camero, Br. J. Cancer 87, 129 (2002).
24. C. Paris, J. Bertoglio, and J. Breard, Apoptosis 12, 1257 (2007).
25. N. Papo and Y. Shai, Life Sci. 62, 784 (2005)